BIIB
Biogen (BIIB) Investor Questions
Review Biogen (BIIB) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Biogen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Overall BTI score
- 65
- Annual revenue
- $9.81B
- Annual net income
- $1.29B
- Annual free cash flow
- $2.05B
Biogen (BIIB) Investor Questions research
Biogen trades under the ticker BIIB. The company is classified in the Healthcare sector and the Drug Manufacturers - General industry.
Investors commonly review BIIB through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.